Atlas Trials

Anticholinergic Deprescription in Schizophrenia

Clinical trial NCT06562608 · RECRUITING

Trial details

NCT number
NCT06562608
Sponsor
Deepak K. Sarpal, M.D.
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
SchizophreniaSchizoaffective Disorder
Start date
2025-02-01
Primary completion
2028-12-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.